Myeloid colony-stimulating factors: Use in the newborn

Archives of Pediatrics and Adolescent Medicine

Volumn 153, Issue 9, 1999, Pages 984-988

  Sreenan, Con ^a   Osiovich, Horacio ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

DRUG EFFICACY; DRUG SAFETY; HUMAN; LEUKOCYTE COUNT; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; NEUTROPENIA; NEUTROPHIL; NEWBORN; PRIORITY JOURNAL; REVIEW; SEPSIS;

EID: 0032869075     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.153.9.984     Document Type: Review

References (65)

1. Gladstone IM, Ehrenkrantz RA, Edberg SC, Baltimore RS. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990;9:819-825.
2. Hill H. Host defences in the neonate: prospects for enhancement. Semin Perinatol. 1985;9:2-11.
3. Keonig J, Christensen RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med. 1989;321:557-562.
4. Doron M, Maklouf R, Katz V, Lawson E, Stiles A. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J Pediatr. 1994;125:452-458.
5. Rodwell RL, Faims PHD, Taylor KMCD, Tudehope DI, Gray PH. Hematologic scoring system in early diagnosis of sepsis in neutropenic new-borns. Pediatr Infect Dis J. 1993;12:372-376.
6. Wolach B. Neonatal sepsis: pathogenesis and supportive therapy. Semin Perinatol. 1997;21:28-38.
7. Fanaroff AA, Korones SB, Wright CL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants: the National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J. 1998;17:593-598.
8. Mathur NB, Singh A, Sharma VK, Satyanarayana L. Evaluation of risk factors for neonatal sepsis. Indian Pediatr. 1996;33:817-822.
9. Cairo M. Granulocyte transfusions in neonates with presumed sepsis. Pediatrics. 1987;80:738-740.
10. Fanaroff AA, Korones SB, Wright L, et al. A controlled trial of intravenous immunoglobulin to reduce nosocomial infections in very low-birth-weight infants. N Engl J Med. 1994;330:1407-1413.
11. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986;232:61-65.
12. Morstyn G, Campbell L, Souza LM, et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1988;1:667-672.
13. Christensen RD, Developmental granulopoiesis. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1998;1753-1761.
14. Athens JW, Raab SO, Haab OP. et al. Leukokinetic studies, III: the distribution of granulocytes in the blood of normal subjects. J Clin Invest. 1961; 40:159-164.
15. Cairo MS. Review of G-CSF and GM-CSF: effect on neonatal neutrophil kinetics. Am J Pediatr Hematol Oncol. 1989;11:238-244.
16. Christensen RD, Rothstein G. Pitfills in the interpretation of leukocyte counts of newborn infants. Am J Clin Pathol. 1979;72:608-611.
17. Bishop CR, Rothstein G, Ashenbrucker HE, Athens JW. Leukokinetic studies, XIV: blood neutrophil kinetics in chronic steady state neutropenia. J Clin Invest. 1971;50:1678-1689.
18. Sola M, Christensen RD. Use of hematopoietic growth factors in the neonatal intensive care unit. J Intensive Care Med. 1997;12:187-205.
19. Ohls RK, Li Y, Abdel-Mageed A, et al Neutrophil pool sizes and granulocyte colony-stimulating factor production in human mid-trimester fetuses. Pediatr Res. 1995;37:806-811.
20. Thomas DB, Yoffey JM. Human fetal hematopoiesis, I: the cellular composition of fetal blood. Br J Hematol. 1962;8:290-295.
21. Playfair JHL, Wolfendale MR, Kay HEM. The leukocytes of peripheral blood in the human fetus. Br J Hematol. 1963;9:336-344.
22. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease, I: reference values for neutrophilic cells. J Pediatr. 1979;95:89-98.
23. Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Revised reference ranges for circulating neutrophils in very low-birth-weight neonates. Pediatrics. 1994;94:76-82.
24. Christensen RD, Macfarlane JL, Taylor NL, et al. Blood and marrow neutrophils during experimental group B streptococcal infection: quantification of the stem cell, proliferation, storage, and circulating pools. Pediatr Res. 1982;16:549-553.
25. Christensen RD, Harper TE, Rothstein G, Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr. 1986;109:1047-1051.
26. Weisbart RH, Gasson JC, Golde DW, Colony-stimulating factors and host defence. Ann Intern Med. 1989;110:297-303.
27. Welte K, Bonilla MA, Gillio AP, et al. Recombinant human granulocyte colony-stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med. 1987;165:941-948.
28. Nicola NA, Metcalf D, Matsumoto M, Johnson GR. Purification of a factor inducing differentiation in murine myelomonocytic leukemic cells: identification as granulocyte colony-stimulating factor (G-CSf). J Biol Chem. 1983;258:9017-9023.
29. Welte K, Platzer E, Lu L, et al. Purification and biochemical characterization for human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A. 1985;82:1526-1530.
30. Simmers RN, Webber LM, Shannon MF, et al. Location of the G-CSF gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute promyelocytic leukemia. Blood. 1987;70:330-332.
31. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989; 320:1574-1580.
32. Kojima S, Fukuda M, Miyajima Y, Matsuyama T, Horibe K. Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood. 1991;77:937-941.
33. Pui CH, Boyett JM, Hughes WT, et al. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med. 1997;336:1781-1787.
34. Donadieu J, Boutard P, Bernatowska E, et al. A European phase II study of recombinant human granulocyte colony-stimulating factor (Lenograstrim) in the treatment of severe chronic neutropenia in children: Lenograstrim Study Group. Eur J Pediatr. 1997;156:693-700.
35. Sheridan W, Morstyn G, Wolf M, et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. 1989; 2:891-895.
36. Bailie KEM, Irvine AE, Bridges JM, McGlure BG. Granulocyte and granulocyte-macrophage colony-stimulating factor in cord and maternal serum at delivery. Pediatr Res. 1994;35:164-168.
37. Gessler P, Kirchmann N, Kientsch-Engel R, Haas N, Lasch P, Kachel W, Serum concentrations of granulocyte colony stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood. 1993;82:3177-3182.
38. Schibler KR, Liechty KW, White WL, Christensen RD. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates. Blood. 1993;82:2478-2484.
39. Shimada M, Minato M, Takado M, Takahashi S, Harada K. Plasma concentrations of granulocyte-colony-stimulating factor in neonates. Acta Pediatr. 1996;85:351-355.
40. Wilimas JA, Wall JE, Fairclough DL, et al. A longitudinal study of granulocyte colony-stimulating factor levels and neutrophil counts in newborn infants. J Pediatr Hematol Oncol. 1995;17:176-179.
41. Cairo M, Gillan E, Buzby J, van de Ven C, Suen Y. Circulating Steel Factor (SLF) and G-CSF levels in preterm and term newborn and adult peripheral blood. Am J Pediatr Hematol Oncol. 1993;15:311-315.
42. Ikeno K. Increased granulocyte-colony stimulating factor levels in neonates with perinatal complications. Acta Pediatr Jpn. 1994;36:366-370.
43. Cairo MS, Suen Y, Knoppel E, et al. Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborn infants. Pediatr Res. 1992;31:574-578.
44. Lee SM, Knoppel E, van de Ven C, Cairo MS. Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin 3, and macrophage colony-stimulating factor genes in activated cord versus adult mononuclear cells: alteration in cytokine expression may be secondary to posttranscriptional instability. Pediatr Res. 1993;34:560-564.
45. Roberts RL, Scelz CM, Scales SM, et al. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor. AJDC. 1991;145:808-812.
46. Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS. A randomized placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 1994;84:1427-1433.
47. Bedford Russell AR, Graham Davies E, Ball SE, Sordon-Smith E. Granulocyte colony stimulating factor treatment for neonatal neutropenia. Arch Dis Child. 1995;72:F53-F54.
48. Kocherlakota P, La Gamma EF. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics [serial online]. 1997;100:1. Available at: http://www.pediatrics .org/content/full/100/1/e6. Accessed July 1997.
49. Kocherlakota P, La Gamma EF. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged pre-eclampsia associated neutropenia. Pediatrics. 1998;102:1107-1111.
50. Makhlouf RA, Doron MW, Bose CL, Price WA, Stiles AD. Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia. J Pediatr. 1995;126:454-456.
51. La Gamma EF, Alpan O, Kocherlakota P. Effect of granulocyte colony-stimulating factor on preeclampsia-associated neonatal neutropenia. J Pediatr. 1995;126:457-459.
52. Schibler KR, Osborne KA, Leung LY, Le TV, Baker SI, Thompson DD. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics. 1998;102:6-13.
53. Calhoun DA, Rosa C, Christensen RD. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol. 1996;174:1306-1311.
54. Nemunaitis J. Granulocyte macrophage-colony-stimulating factor: a review from preclinical development to clinical application. Transfusion. 1993;33:70-83.
55. Cairo MS, van de Ven C, Toy C, Mauss D, Sender L. Recombinant human granulocyte-macrophage colony-stimulating factor primes neonatal granulocytes for enhanced oxidative metabolism and chemotaxis. Pediatr Res. 1989;26:395-399.
56. Cairo MS, Christensen RD, Sender LS, et al. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birth weight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood. 1995;86:2509-2515.
57. Cairo M, Suen T, Fanaroff A, et al. A double-blinded, randomized, placebo controlled pilot study of rhu GM-CSF in low-birth-weight neonates: preliminary results demonstrate a significant reduction in nosocomial infections with rhu GM-CSF [abstract]. Pediatr Res. 1996;39:294a.
58. Carr R, Modi N. Haematopoietic colony stimulating factors for preterm neonates. Arch Dis Child. 1997;76:F128-F133.
59. Bedford Russell AR. New modalities for treating neonatal infection. Eur J Pediatr. 1996;155(suppl): S21-S24.
60. Barak Y, Leibovitz E, Mogilner B, et al. The in vivo effect of recombinant human granulocyte colony-stimulating factor in neutropenic neonates with sepsis. Eur J Pediatr. 1997;156:643-646.
61. Leischke GJ, Cebon J, Morstyn G. Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 1989;74:2634-2643.
62. Leischke GJ, Maher D, O'Connor M, et al. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Cancer Res. 1990;50:606-614.
63. Bonilla MA, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor in patients with severe congenital neutropenias. Br J Hematol. 1994;88:723-730.
64. Naparstek E. Granulocyte colony-stimulating factor, congenital neutropenia, and acute myeloid leukemia. N Engl J Med. 1995;333:516-518.
65. Rosenthal J, Healey T, Ellis R, Gillan E, Cairo MS. A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life. J Pediatr. 1996;128:135-137.